[go: up one dir, main page]

AR021719A1 - ANTIESTROGEN ORAL PHARMACEUTICAL COMPOSITION. - Google Patents

ANTIESTROGEN ORAL PHARMACEUTICAL COMPOSITION.

Info

Publication number
AR021719A1
AR021719A1 ARP990106464A ARP990106464A AR021719A1 AR 021719 A1 AR021719 A1 AR 021719A1 AR P990106464 A ARP990106464 A AR P990106464A AR P990106464 A ARP990106464 A AR P990106464A AR 021719 A1 AR021719 A1 AR 021719A1
Authority
AR
Argentina
Prior art keywords
antiestrogen
pharmaceutical composition
oral pharmaceutical
formula
antiestrogen oral
Prior art date
Application number
ARP990106464A
Other languages
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR021719A1 publication Critical patent/AR021719A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una forma de dosificacion oral del antiestrogeno de la formula 1 que se puede administrar a un mamífero de sexo femenino que ha ayunado oingerido alimentos, que comprende el antiestrogeno de la formula 1, una cantidad efectiva de por lom enos un desintegrante y una cantidad efectiva de untensioactivo suficiente para obtener una relacion ABCalim/ABCayuno inferior a aproximadamente 15.An oral dosage form of the antiestrogen of formula 1 is described which can be administered to a female mammal who has fasted oingerid food, comprising the antiestrogen of formula 1, an effective amount of at least one disintegrant and an amount. Effective enough surfactant to obtain an ABCalim / ABC breakfast ratio less than about 15.

ARP990106464A 1998-12-18 1999-12-16 ANTIESTROGEN ORAL PHARMACEUTICAL COMPOSITION. AR021719A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21643198A 1998-12-18 1998-12-18

Publications (1)

Publication Number Publication Date
AR021719A1 true AR021719A1 (en) 2002-07-31

Family

ID=22807038

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106464A AR021719A1 (en) 1998-12-18 1999-12-16 ANTIESTROGEN ORAL PHARMACEUTICAL COMPOSITION.

Country Status (3)

Country Link
AR (1) AR021719A1 (en)
AU (1) AU2156800A (en)
WO (1) WO2000037083A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297446B6 (en) * 2004-09-30 2006-12-13 Pliva - Lachema A. S. Process for preparing oral solid medicamentous form and oral medicamentous form prepared thereby
MX2012014431A (en) 2010-06-10 2013-02-26 Aragon Pharmaceuticals Inc MODULAR RECEPTOR OF STROGENS AND USES OF THE SAME.
JP2015500346A (en) 2011-12-14 2015-01-05 セラゴン ファーマシューティカルズ，インク． Estrogen receptor modulators and uses thereof
MX2014007198A (en) 2011-12-16 2014-10-13 Olema Pharmaceuticals Inc Novel benzopyran compounds, compositions and uses thereof.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5726186A (en) * 1995-09-08 1998-03-10 Eli Lilly And Company Pentacyclic compounds, intermediates, processes, compositions, and methods
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Also Published As

Publication number Publication date
AU2156800A (en) 2000-07-12
WO2000037083A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
CO5190672A1 (en) COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION
ATE514418T1 (en) RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN
AP1450A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
TR200002207T1 (en) Slekoksib compounds.
AR022008A1 (en) A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT
ES2181417T3 (en) FORMULATION OF CAPSULES OR TABLETS OF EFAVIRENZ OF FAST DISSOLUTION USING SUPER-DISINTEGRANTS.
UY27296A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MOSAPRIDE AND PANCREATIN
PA8562201A1 (en) DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS
AR018109A1 (en) ADMINISTRABLE GALENIC FORMULATION BY ORAL ROUTE THAT ALLOWS AN IMPROVED ABSORPTION OF ACTIVE PRINCIPLES, USE OF AN ABSORPTION MAJORATING AGENT TO PREPARE AN ADMINISTRABLE DOSAGE METHOD BY ORAL ROUTE AND PROCEDURE TO PREPARE THE GINAL FORMULA
GT199900061A (en) PHARMACEUTICAL FORMULATIONS.
AR033796A1 (en) PHARMACEUTICAL COMPOSITION
BRPI9811803B8 (en) fast-dissolving improved multiparticulate tablet
AR038527A1 (en) DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS ACTIVE INGREDIENT
ES2142499T3 (en) MODAFINIL WITH A DEFINED GRANULOMETRY.
AR067495A1 (en) PHARMACEUTICAL COMPOSITIONS AND PROCEDURE DRY EYE DISORDER TREATMENTS
AR034607A1 (en) HAIR CONDITIONING COMPOSITIONS
ES2167061T3 (en) DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS.
AR028299A1 (en) A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
BR9406514A (en) Therapeutic compositions of stable nadh and nadh that can be ingested and absorbed
AR059764A2 (en) PROCESS TO PREPARE A PHARMACEUTICAL COMPOSITION OF RITONAVIR AND COMPOSITION OBTAINED
ES2152731T3 (en) PRODUCT TO INCREASE CONFORMABILITY AND HAIR BRIGHTNESS.
ES2178896T3 (en) NEW FORM OF SALT OF PANTOPRAZOL.
BR0212778A (en) Organoleptically acceptable intraoral disintegrating compositions
BRPI0412697A (en) pharmaceutical compositions having an expandable coating
ES2191987T3 (en) DOSAGE FORMS OF RIBAVIRINA SOLIDAS, ADMINISTRABLE ORALALLY, AND MANUFACTURING PROCEDURE.